In rabbit studies with 0.8 cm radial bone defects that remained incompletely healed in all control animals for 6 weeks, BPC-157 treatment (administered locally into the bone defect or intramuscularly) produced healing comparable to standard treatments including local bone marrow application or autologous cortical bone grafting
Those seeking vascular and neurological support, and especially well-suited to athletes, post-operative patients, and individuals in need of accelerated healing in general
65 However, as this was an open-label, uncontrolled trial, it is impossible to assess how much of the improvement was due to a placebo effect
Our peptide reconstitution calculator calculates injection volumes automatically
Anhedonia (loss of pleasure), induced by ketamine 30 mg/kg reducing sucrose preference over 72 hours, was counteracted by BPC-157 with sustained benefit across multiple days